Anti-CD22 (Epratuzumab)-Mc-MMAF ADC

TypeName: Business Offer
Category:
Country: United States
Summary: This ADC product is comprised of a Epratuzumab conjugated via a MC linker to a MMAF. The MMAF is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the cell, MMAF binds to tubulins, interrupts microtubule dynamics, and subsequently, induces cell death. http://www.creative-biolabs.com/adc/target-cd22-10.htm
Description: [RequestDescription]
OfferId: 2553
Name:Creative Biolabs
Telphone:
Categories